BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33761608)

  • 1. FENDRR: A pivotal, cancer-related, long non-coding RNA.
    Zheng Q; Zhang Q; Yu X; He Y; Guo W
    Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer.
    Xu W; Wang B; Cai Y; Chen J; Meng E; Guo C; Zhou G; Yuan C
    Curr Pharm Des; 2021; 27(39):4100-4106. PubMed ID: 34414867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of LncRNA FENDRR in Multiple Cancers: A Review.
    Fazaeli H; Sheikholeslami A; Ghasemian F; Amini E; Sheykhhasan M
    Curr Mol Med; 2023 May; 23(7):606-629. PubMed ID: 35579154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FENDRR Expression Correlates with Tumor Immunogenicity.
    Munteanu MC; Sethuraman SN; Singh MP; Malayer J; Ranjan A
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung-specific distant enhancer cis regulates expression of FOXF1 and lncRNA FENDRR.
    Szafranski P; Gambin T; Karolak JA; Popek E; Stankiewicz P
    Hum Mutat; 2021 Jun; 42(6):694-698. PubMed ID: 33739555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
    Kun-Peng Z; Chun-Lin Z; Xiao-Long M
    Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of lncRNA
    Herrera-Merchan A; Cuadros M; Rodriguez MI; Rodriguez S; Torres R; Estecio M; Coira IF; Loidi C; Saiz M; Carmona-Saez P; Medina PP
    Oncotarget; 2020 Mar; 11(13):1172-1185. PubMed ID: 32284793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.
    Pan H; Yu T; Sun L; Chai W; Liu X; Yan M
    Transl Cancer Res; 2020 Jun; 9(6):3946-3959. PubMed ID: 35117761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.
    Yang L; Wu D; Chen J; Chen J; Qiu F; Li Y; Liu L; Cao Y; Yang B; Zhou Y; Lu J
    Carcinogenesis; 2018 Mar; 39(3):347-359. PubMed ID: 29293945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fendrr involves in the pathogenesis of cardiac fibrosis via regulating miR-106b/SMAD3 axis.
    Gong L; Zhu L; Yang T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):169-177. PubMed ID: 31982134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA
    Szafranski P; Stankiewicz P
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA HOXD-AS1 in cancer.
    Li L; Wang Y; Zhang X; Huang Q; Diao Y; Yin H; Liu H
    Clin Chim Acta; 2018 Dec; 487():197-201. PubMed ID: 30290157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights for lncRNA MAGI2-AS3 in solid tumors.
    Xue C; Li G; Lu J; Luo J; Jia J
    Biomed Pharmacother; 2021 May; 137():111429. PubMed ID: 33761624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA LOC285194 in cancer.
    Luo L; Wang M; Li X; Tian J; Zhang K; Tan S; Luo C
    Clin Chim Acta; 2020 Mar; 502():1-8. PubMed ID: 31837299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.
    Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y
    Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-DANCR: A valuable cancer related long non-coding RNA for human cancers.
    Thin KZ; Liu X; Feng X; Raveendran S; Tu JC
    Pathol Res Pract; 2018 Jun; 214(6):801-805. PubMed ID: 29728310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of long non-coding RNAs and MEF2C-AS1 identified as a novel biomarker in diffuse gastric cancer.
    Luo T; Zhao J; Lu Z; Bi J; Pang T; Cui H; Yang B; Li W; Wang Y; Wu S; Xue X
    Transl Oncol; 2018 Oct; 11(5):1080-1089. PubMed ID: 30005210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.